CMMB News and Press, Chemomab Therapeutics Ltd. From 06/11/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We’re approaching the end of trading for the week but we’ve got one more day of market coverage to bring you. Of course, we’re starting that off with a look at the biggest pre-m...

Chemomab Announces Poster Presentation at the International Liver Congress 2021 (EASL) PR Newswire TEL AVIV, Israel , June 10, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd . (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and deve...

Nabriva Therapeutics (NBRV) +51% as its Nabriva antibiotic meets primary endpoint.Pieris Pharmaceuticals (PIRS) +20%.Protagenic Therapeutics (PTIX) +11%.Zscaler (ZS) +11% on Q3 results.Urban Outfitters (URBN) +11% on Q1 results.Selecta Biosciences (SELB) +10% as board dire...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Chemomab Therapeutics - ADR (CMMB): Q1 Net loss of $1.7MCash and cash equivalents of $58.2MPress Release For further details see: Chemomab Therapeutics - ADR reports Q1 results

Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update Announced positive data from its Phase Ib SPARK study evaluating CM-101 in NAFLD patients Announced first patient enrolled in two Phase IIa studies of CM-101 Completed mer...

Chemomab to Present at Oppenheimer's Virtual Rare and Orphan Disease Summit PR Newswire TEL AVIV, Israel , May 12, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd . (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of in...

iBio (IBIO) +33% on COVID-19 study update.Orgenesis (ORGS) +11% on Q1 results.Chemomab Therapeutics (CMMB) +12%.T2 Biosystems, Inc. (TTOO) +11% on Q1 results.ViewRay (VRAY) +12%.Epizyme (EPZM) +11% on Q1 results.CureVac N.V. (CVAC) +9%.Roku (ROKU) +9% on Q1 results.Da...

Chemomab Announces Enrollment of First Patient in Phase 2a Study of CM-101 in Non-Alcoholic Steatohepatitis (NASH) The study aims to further validate the anti-fibrotic and anti-inflammatory activity of CM-101 while providing safety and PK data to support development of the subcu...

Chemomab Announces Four New Appointments to the Board of Directors and Completion of PIPE Financing PR Newswire TEL-AVIV, Israel , March 29, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the disco...